Neurotrack Technologies, Inc.
PrivateLast Round
Series C
Extension
Nov 2, 2022
Total Funding Raised
$55.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neurotrack Technologies, Inc. is a digital health company that develops clinically validated digital cognitive assessment and behavior-change tools to facilitate the early detection and management of Alzheimer's disease and other dementias.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Mental Health
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurotrack Technologies, Inc. Comparables
Compare Neurotrack Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creyos | 91% | |
| BrainCheck | 87% | |
| Altoida, Inc. | 86% |
Neurotrack Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Nov 2, 2022 | ||||
| Series C | Jun 11, 2019 | ||||
| Grant | Apr 17, 2019 | ||||
| Series B | Mar 20, 2018 | ||||
| VC Round | Jan 27, 2016 | ||||
Debt | Dec 29, 2014 |
Key People
Founding team and executive leadership
Neurotrack Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rock Health | Accelerator |
| Khosla Ventures | Series B, VC Round, Series C |
| Founders Fund | Series B, VC Round, Series A |
| Rethink Impact | Series B, Series C |
| Social Capital | Series B, VC Round, Series A |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 38% MoM, reaching 16.9K.
- Jun 19, 2026
Monthly visitors increased 35% MoM, reaching 12.2K.
Recent news
Latest coverage and updates
- has_revenueAug 10, 2026
Neurotrack has estimated revenue of $4.2M in Sep '25.
Neurotrack Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurotrack Technologies, Inc.'s valuation, stock price, and market status.
Is Neurotrack Technologies, Inc. a public or private company?
Neurotrack Technologies, Inc. is a private company.
What is the current stock price of Neurotrack Technologies, Inc.?
Neurotrack Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks Neurotrack Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurotrack Technologies, Inc. worth (valuation)?
Valuation information for Neurotrack Technologies, Inc. is not publicly available.
Can I buy Neurotrack Technologies, Inc. stock?
Neurotrack Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurotrack Technologies, Inc.'s last funding round?
Neurotrack Technologies, Inc.'s most recent funding round was Series C Extension on November 2, 2022.
Who are the main investors in Neurotrack Technologies, Inc.?
Key investors in Neurotrack Technologies, Inc. include Rock Health, Khosla Ventures, Founders Fund, Sozo Ventures.
Will Neurotrack Technologies, Inc. IPO soon?
No public IPO plans have been announced for Neurotrack Technologies, Inc..
How can I track Neurotrack Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Neurotrack Technologies, Inc.'s shares on secondary markets.